摘要
The 2016 revision of the“Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults”is the outcome of the joint efforts of the members of an expert panel for more than 1 year,and is based on the 2007 guidelines.There is no doubt that the release of the 2007 guidelines greatly facilitated the management of dyslipidemia and the prevention and treatment of atherosclerotic cardiovascular diseases(ASCVDs)in China.However,an update of the guidelines for the management of dyslipidemia in Chinese adults is urgently needed since huge changes have occurred in the concepts of dyslipidemia research and control during the last decade.
